Skip to main content

LIVE

CERT

Certara, Inc.

CERT

NASDAQ·Healthcare·Medical - Healthcare Information Services·Mkt cap $1.2B

$7.94

-2.34%

P/E

-18.32

Mkt Cap

$1.2B

52-Wk Range

$4.45–$13.88

52-Week Range

$4.45 - $13.88

P/E

-18.32

Fwd P/E

23.23

Beta

1.41

Div Yield

0.00%

Avg Vol

3.8M

Shares Out

153.3M

Mkt Cap

$1.2B

Price action

Price chart

Down 25.8% over the trailing year

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

Bull Case

4 reasons

  • Proprietary biosimulation and mechanistic modeling technology
  • Comprehensive end-to-end drug development solutions
  • Strong customer relationships with top-20 pharmaceutical companies
  • Skilled workforce of scientific and regulatory experts

Bear Case

2 risks

  • Average volatility.
  • Premium valuation to Healthcare IT & Services peers

Growth

Turning profitable

Increased adoption of model-based drug development approaches

Value

Premium valuation to Healthcare IT & Services peers

Momentum

Hot

+52.1% over 3m

Quality

Strong

Solid business

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Nov 5, 2026

Q3 26 RECAP

AUG 4, 2026

Reported EPS of $0.08 vs $0.09 consensus (-10.4% surprise). Revenue of $93.3M vs $98.1M expected (-4.9%).

EPS miss
Revenue miss

EPS surprise · last 4Q

0 of 1 beats

Estimate

Actual

Q3 26

-10.4%

Revenue trend · last 8Q

+10%

+12%

+10%

+3%

+1%

-23%

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

Q2 26

$94.8M

$100.4M

$106.0M

$104.6M

$104.6M

$103.6M

$106.9M

$80.4M

Margins · last 8Q

Gross

83.1%

Operating

-0.2%

Profit

-11.4%

Wall Street consensus

7 analysts · 29% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

2

29%

Hold

5

71%

Sell

0%

Median Price Target

Latest: Barclays · May 12, 2026

vs Industry

How CERT stacks vs Medical - Healthcare Information Services

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.